Search clinical trials for: ofatumumab (GSK1841157) infusion
Total 4643 results
-
Massachusetts General HospitalGlaxoSmithKline; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical...CompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States
-
Novartis PharmaceuticalsTerminatedLeukaemia, Lymphocytic, ChronicSpain, United States, Belgium, India, United Kingdom, Netherlands, Czechia, Germany, Greece, Italy, Russian Federation, Sweden, Canada, Ireland, Poland, France, Brazil
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
Novartis PharmaceuticalsTerminatedLymphoma, FollicularUnited States, Belgium, Italy, Hong Kong, Austria, Germany, Japan, Russian Federation, United Kingdom, Canada, Slovakia, Poland, Ukraine, Puerto Rico, Greece, France, Argentina
-
The University of New South WalesCompletedUlcerative Colitis | Inflammatory Bowel DiseaseAustralia
-
Emory UniversityNovartisTerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
GlaxoSmithKlineTerminatedArthritis, RheumatoidUnited States, Denmark, Hungary, United Kingdom, Poland
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
GlaxoSmithKlineCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Thrombocytopenia | Fever | Chronic Lymphocytic Leukemia | Lymphadenopathy | Small Lymphocytic Lymphoma | Hypogammaglobulinemia | Lymphocytosis | Night Sweats | ParaproteinemiaUnited States
-
Novartis PharmaceuticalsCompleted
-
Fondazione Italiana Linfomi ONLUSCompletedFollicular Lymphoma, Grade 1 | Follicular Lymphoma, Grade 2 | Follicular Lymphoma Grade 3AItaly
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic and Lymphoma, FollicularJapan
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)France
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingLeukemia, Lymphoblastic, ChronicItaly
-
Michael John RobertsonNovartisCompletedNon-Hodgkin's LymphomaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Pharmacyclics LLC.Ohio State UniversityCompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's Transformation | Prolymphocyctic LeukemiaUnited States
-
Novartis PharmaceuticalsRecruiting
-
Joseph TuscanoGlaxoSmithKlineCompletedChronic Lymphocytic LeukemiaUnited States
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicKorea, Republic of, Japan
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
University Health Network, TorontoNovartisCompletedChronic Lymphocytic Leukemia (CLL)Canada
-
Novartis PharmaceuticalsCompletedMultiple SclerosisUnited States, Austria, Spain, Czechia, Estonia, Bulgaria, Latvia, Lithuania, Russian Federation
-
Brown UniversityThe Miriam Hospital; Dartmouth-Hitchcock Medical Center; Rhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedLymphoma, Non-HodgkinsUnited States
-
GlaxoSmithKlineCompletedArthritis, RheumatoidRussian Federation, Australia, Belgium, Spain, United States, New Zealand, Italy, Poland, France
-
GlaxoSmithKlineTerminatedArthritis, RheumatoidPoland, Russian Federation, Argentina, Belgium, Peru, Spain, Australia, Czechia, South Africa, Chile, Hungary, United Kingdom, Romania
-
GlaxoSmithKlineCompleted
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonWithdrawnChronic Lymphocytic Leukemia (CLL)United States
-
Januario Castro, M.D.GlaxoSmithKlineCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedChronic Graft Versus Host DiseaseUnited States
-
GlaxoSmithKlineCompletedWaldenstrom MacroglobulinaemiaUnited States
-
University of CologneCompleted
-
GlaxoSmithKlineCompletedLymphoma, Large-Cell, DiffuseUnited Kingdom
-
Novartis PharmaceuticalsCompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedWaldenström MacroglobulinemiaUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedMantle Cell LymphomaUnited States
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsRecruitingRelapse Remitting Multiple SclerosisUnited States, Puerto Rico
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
M.D. Anderson Cancer CenterGlaxoSmithKlineCompletedChronic Lymphocytic LeukemiaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
SCRI Development Innovations, LLCGlaxoSmithKlineCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Completed